Prevalence of painful peripheral neuropathy in a screening program looking at risk for developing diabetic foot in a public Peruvian hospital

Descripción del Articulo

Objective: To determine prevalence of painful asymptomatic peripheral neuropathy (PN) in persons with type 2 diabetes mellitus (DM2) and its associated characteristics. Materials and Methods: This is a cross-sectional descriptive study performed in patients belonging to the program ‘Feet at risk’ at...

Descripción completa

Detalles Bibliográficos
Autores: Rivera-Grimaldo, Luisa S., Cuadra-Minchan, Karen S., Yovera-Aldana, Marlon
Formato: artículo
Fecha de Publicación:2024
Institución:Colegio Médico del Perú
Repositorio:Acta Médica Peruana
Lenguaje:español
OAI Identifier:oai:amp.cmp.org.pe:article/2894
Enlace del recurso:https://amp.cmp.org.pe/index.php/AMP/article/view/2894
Nivel de acceso:acceso abierto
Materia:Diabetes Mellitus tipo 2
Neuropatías diabéticas
estudios transversales
servicio ambulatorio en hospital
prevalencia
fenotipo
Diabetes mellitus, Type 2
diabetic neuropathies
cross-sectional Studies
Outpatient Clinics, Hospital
Prevalence
Phenotype
id REVCMP_afc6c8daa87ef8b2352a8aede40ed7ee
oai_identifier_str oai:amp.cmp.org.pe:article/2894
network_acronym_str REVCMP
network_name_str Acta Médica Peruana
repository_id_str .
dc.title.none.fl_str_mv Prevalence of painful peripheral neuropathy in a screening program looking at risk for developing diabetic foot in a public Peruvian hospital
Prevalencia de neuropatía periférica dolorosa y asintomática de un programa de tamizaje para riesgo de pie diabético en un hospital público peruano
title Prevalence of painful peripheral neuropathy in a screening program looking at risk for developing diabetic foot in a public Peruvian hospital
spellingShingle Prevalence of painful peripheral neuropathy in a screening program looking at risk for developing diabetic foot in a public Peruvian hospital
Rivera-Grimaldo, Luisa S.
Diabetes Mellitus tipo 2
Neuropatías diabéticas
estudios transversales
servicio ambulatorio en hospital
prevalencia
fenotipo
Diabetes mellitus, Type 2
diabetic neuropathies
cross-sectional Studies
Outpatient Clinics, Hospital
Prevalence
Phenotype
title_short Prevalence of painful peripheral neuropathy in a screening program looking at risk for developing diabetic foot in a public Peruvian hospital
title_full Prevalence of painful peripheral neuropathy in a screening program looking at risk for developing diabetic foot in a public Peruvian hospital
title_fullStr Prevalence of painful peripheral neuropathy in a screening program looking at risk for developing diabetic foot in a public Peruvian hospital
title_full_unstemmed Prevalence of painful peripheral neuropathy in a screening program looking at risk for developing diabetic foot in a public Peruvian hospital
title_sort Prevalence of painful peripheral neuropathy in a screening program looking at risk for developing diabetic foot in a public Peruvian hospital
dc.creator.none.fl_str_mv Rivera-Grimaldo, Luisa S.
Cuadra-Minchan, Karen S.
Yovera-Aldana, Marlon
Rivera-Grimaldo, Luisa S.
Cuadra-Minchan, Karen S.
Yovera-Aldana, Marlon
author Rivera-Grimaldo, Luisa S.
author_facet Rivera-Grimaldo, Luisa S.
Cuadra-Minchan, Karen S.
Yovera-Aldana, Marlon
author_role author
author2 Cuadra-Minchan, Karen S.
Yovera-Aldana, Marlon
author2_role author
author
dc.subject.none.fl_str_mv Diabetes Mellitus tipo 2
Neuropatías diabéticas
estudios transversales
servicio ambulatorio en hospital
prevalencia
fenotipo
Diabetes mellitus, Type 2
diabetic neuropathies
cross-sectional Studies
Outpatient Clinics, Hospital
Prevalence
Phenotype
topic Diabetes Mellitus tipo 2
Neuropatías diabéticas
estudios transversales
servicio ambulatorio en hospital
prevalencia
fenotipo
Diabetes mellitus, Type 2
diabetic neuropathies
cross-sectional Studies
Outpatient Clinics, Hospital
Prevalence
Phenotype
description Objective: To determine prevalence of painful asymptomatic peripheral neuropathy (PN) in persons with type 2 diabetes mellitus (DM2) and its associated characteristics. Materials and Methods: This is a cross-sectional descriptive study performed in patients belonging to the program ‘Feet at risk’ at the Endocrinology Service in Maria Auxiliadora National Hospital. Patients with DM2 who were seen between 2015 and 2020 were included. The definition of PN is according to Toronto Consensus, considering the evaluation of three components: symptoms, signs and Achilles reflex, determining certainty as possible and probable, according to the combinations found. For assessing symptoms, the total symptom score (TTS) was used; for signs, monofilament test was used, and vibration sensitivity was assessed using a 128-Hz tuning fork. Prevalence of PN was calculated according to symptoms and certainty of the diagnosis. Also, the clinical characteristics of patient groups were described. Results: One-thousand and six persons were included, their mean age was 60,5 years, and 69,3% were female. In those who had at least one item from Toronto criteria, 60,5% had painful PN, and 21,8% had asymptomatic PN. When using more diagnostic certainty, i.e., two from three criteria being positive, the prevalence of painful PN was 42,2% and for asymptomatic PN, it was 6,5%. Four groups with different distributions with respect to sex, time with diabetes, ulcer history, peripheral arterial disease and glycemic control were established. Conclusion: In patients from the Endocrinology Service at Maria Auxiliadora Hospital 42,2% and 6,5% had more certainty for presenting with probable painful PN and asymptomatic PN, respectively. Further studies are needed for confirming the usefulness of the aforementioned criteria for properly estimating the burden of disease.
publishDate 2024
dc.date.none.fl_str_mv 2024-06-30
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://amp.cmp.org.pe/index.php/AMP/article/view/2894
10.35663/amp.2024.412.2894
url https://amp.cmp.org.pe/index.php/AMP/article/view/2894
identifier_str_mv 10.35663/amp.2024.412.2894
dc.language.none.fl_str_mv spa
language spa
dc.relation.none.fl_str_mv https://amp.cmp.org.pe/index.php/AMP/article/view/2894/1635
https://amp.cmp.org.pe/index.php/AMP/article/view/2894/1655
https://amp.cmp.org.pe/index.php/AMP/article/view/2894/1656
dc.rights.none.fl_str_mv Copyright (c) 2024 ACTA MEDICA PERUANA
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2024 ACTA MEDICA PERUANA
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
text/html
text/xml
dc.publisher.none.fl_str_mv Colegio Médico del Perú
publisher.none.fl_str_mv Colegio Médico del Perú
dc.source.none.fl_str_mv ACTA MEDICA PERUANA; Vol. 41 No. 2 (2024): April - June; 92-102
ACTA MEDICA PERUANA; Vol. 41 Núm. 2 (2024): Abril - Junio; 92-102
1728-5917
1018-8800
reponame:Acta Médica Peruana
instname:Colegio Médico del Perú
instacron:CMP
instname_str Colegio Médico del Perú
instacron_str CMP
institution CMP
reponame_str Acta Médica Peruana
collection Acta Médica Peruana
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1842710635053318144
spelling Prevalence of painful peripheral neuropathy in a screening program looking at risk for developing diabetic foot in a public Peruvian hospitalPrevalencia de neuropatía periférica dolorosa y asintomática de un programa de tamizaje para riesgo de pie diabético en un hospital público peruanoRivera-Grimaldo, Luisa S.Cuadra-Minchan, Karen S.Yovera-Aldana, MarlonRivera-Grimaldo, Luisa S.Cuadra-Minchan, Karen S.Yovera-Aldana, MarlonDiabetes Mellitus tipo 2Neuropatías diabéticasestudios transversalesservicio ambulatorio en hospitalprevalenciafenotipoDiabetes mellitus, Type 2diabetic neuropathiescross-sectional StudiesOutpatient Clinics, HospitalPrevalencePhenotype Objective: To determine prevalence of painful asymptomatic peripheral neuropathy (PN) in persons with type 2 diabetes mellitus (DM2) and its associated characteristics. Materials and Methods: This is a cross-sectional descriptive study performed in patients belonging to the program ‘Feet at risk’ at the Endocrinology Service in Maria Auxiliadora National Hospital. Patients with DM2 who were seen between 2015 and 2020 were included. The definition of PN is according to Toronto Consensus, considering the evaluation of three components: symptoms, signs and Achilles reflex, determining certainty as possible and probable, according to the combinations found. For assessing symptoms, the total symptom score (TTS) was used; for signs, monofilament test was used, and vibration sensitivity was assessed using a 128-Hz tuning fork. Prevalence of PN was calculated according to symptoms and certainty of the diagnosis. Also, the clinical characteristics of patient groups were described. Results: One-thousand and six persons were included, their mean age was 60,5 years, and 69,3% were female. In those who had at least one item from Toronto criteria, 60,5% had painful PN, and 21,8% had asymptomatic PN. When using more diagnostic certainty, i.e., two from three criteria being positive, the prevalence of painful PN was 42,2% and for asymptomatic PN, it was 6,5%. Four groups with different distributions with respect to sex, time with diabetes, ulcer history, peripheral arterial disease and glycemic control were established. Conclusion: In patients from the Endocrinology Service at Maria Auxiliadora Hospital 42,2% and 6,5% had more certainty for presenting with probable painful PN and asymptomatic PN, respectively. Further studies are needed for confirming the usefulness of the aforementioned criteria for properly estimating the burden of disease. Objetivo: determinar la prevalencia de la neuropatía periférica (NP) dolorosa y asintomática en personas con diabetes mellitus tipo 2 (DM2) y sus características asociadas. Materiales y métodos: estudio transversal-descriptivo de pacientes del programa de pie en riesgo del Servicio de Endocrinología del Hospital Nacional María Auxiliadora (HMA). Se incluye a pacientes con DM2 atendidos entre el 2015 y el 2020. La definición de NP fue según el Consenso de Toronto, que considera la evaluación de tres componentes: síntomas, signos y reflejo aquíleo, calificando la certeza como posible y probable, según su combinación. Para la evaluación de síntomas se aplicó el puntaje total de síntomas (TTS, del inglés Total Symptom Score); para los signos se usó la prueba de monofilamento y se evaluó la sensibilidad vibratoria con diapasón de 128 Hz. La prevalencia de NP se calculó según sintomatología y la certeza del diagnóstico. Además, se describieron las características clínicas entre los grupos. Resultados: se incluyó a 1006 personas con una edad media de 60,5 años, de las cuales el 69,3% correspondió a mujeres. En aquellos que tenían al menos un criterio de Toronto (neuropatía posible y probable), un 60,5% presentó NP dolorosa y un 21,8% NP asintomática. Utilizando una mayor certeza diagnóstica, es decir, dos de tres criterios positivos (solo neuropatía probable), la prevalencia de NP dolorosa fue del 42,2% y la NP asintomática, 6,5%. Se establecieron cuatro grupos que presentaron distribuciones diferentes respecto a sexo, tiempo de diabetes, antecedente de úlcera, enfermedad arterial periférica y control glicémico. Conclusión: en pacientes del Servicio de Endocrinología del HMA, el 42,2 y el 6,5% presentaron una mayor certeza de presentar NP probable dolorosa y asintomática respectivamente. Se requiere estudios que confirmen la utilidad de estos criterios para estimar correctamente la carga de enfermedad. Colegio Médico del Perú2024-06-30info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdftext/htmltext/xmlhttps://amp.cmp.org.pe/index.php/AMP/article/view/289410.35663/amp.2024.412.2894ACTA MEDICA PERUANA; Vol. 41 No. 2 (2024): April - June; 92-102ACTA MEDICA PERUANA; Vol. 41 Núm. 2 (2024): Abril - Junio; 92-1021728-59171018-8800reponame:Acta Médica Peruanainstname:Colegio Médico del Perúinstacron:CMPspahttps://amp.cmp.org.pe/index.php/AMP/article/view/2894/1635https://amp.cmp.org.pe/index.php/AMP/article/view/2894/1655https://amp.cmp.org.pe/index.php/AMP/article/view/2894/1656Copyright (c) 2024 ACTA MEDICA PERUANAinfo:eu-repo/semantics/openAccessoai:amp.cmp.org.pe:article/28942024-12-05T00:29:41Z
score 12.8608675
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).